Inventor · disambiguated record
Jiaping He
Also filed as: HE JIAPING
6 granted patents·5 pending applications·37 citations·filing 2017–2024
83Inventor score
Files withCELLULAR BIOMEDICINE GROUP HK LTD3CELLULAR BIOMEDICINE GROUP INC3GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD3ABELZETA INC1CELLULAR BIOMEDICINE GROUP SHANGHAI LTD1
Top patents by PatentIndex Score
11 records- 0196US11472858B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Oct 18, 2022·7 cites·4 claims
- 0295US11618778B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 4, 2023·7 cites·6 claims
- 0395US11608369B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Mar 21, 2023·7 cites·6 claims
- 0494US11066457B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2018·Granted Jul 20, 2021·8 cites·8 claims
- 0591US11363812B2Cell freezing medium for clinical useCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2017·Granted Jun 21, 2022·8 cites·11 claims
- 0681US2023242613A1Construction of chimeric antigen receptor targeting cd20 antigen and activity identification of engineered t cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 0774US12356981B2Cell freezing medium for clinical useABELZETA INC·Filed 2022·Granted Jul 15, 2025·0 cites·17 claims
- 0871US2024335474A1Compositions and methods for immunotherapyGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 0959US2021369779A1Compositions and methods for immunotherapyGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1045US2020255803A1Engineered immune cell capable of inducing secretion of anti-cd47 antibodyGRACELL BIOTECHNOLOGIES (SHANGHAI) CO LTD·Filed 2018·Application pending·0 cites
- 1141US2020170242A1Cell cryopreservation formulation and cell recovery methodCELLULAR BIOMEDICINE GROUP SHANGHAI LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiaping He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →